Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1622 1626
This examiner grants 87% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18250504 | SOLUBLE EPOXIDE HYDROLASE (sEH) INHIBITORS AND DUAL COX/sEH INHIBITORS FOR THE TREATMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18079729 | PROCESS FOR MAKING HYDROXYLATED CYCLOPENTYLPYRIMIDINE COMPOUNDS | Non-Final OA | HOFFMANN-LA ROCHE INC. |
| 18209894 | METHOD FOR PREPARING CHIRAL MALEIMIDE DERIVATIVES USING ORGANIC CHIRAL CATALYST COMPOUNDS AND ECO-FRIENDLY SOLVENTS | Non-Final OA | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 18566736 | METHODS OF TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH OPIATE WITHDRAWAL OR OPIATE RELAPSE | Non-Final OA | Proniras Corporation |
| 18284735 | PROCESS FOR PREPARING CHLORANTRANILIPROLE | Non-Final OA | Gharda Chemicals Limited |
| 18243095 | PHARMACEUTICAL COMPOSITIONS COMPRISING 2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE | Non-Final OA | PTC THERAPEUTICS, INC. |
| 17694902 | NITROCATECHOL DERIVATIVES AS COMT INHIBITORS | Final Rejection | BIAL - PORTELA & CA, S.A. |
| 17780083 | Novel Quercetin Redox Derivative And Use Thereof As BET Inhibitor | Non-Final OA | Benobio Co., Ltd. |
| 17771758 | TREATMENT OF CONDITIONS OF THE NERVOUS SYSTEM | Final Rejection | The University of Leeds |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy